User:MenloBiotech/sandbox

Stanley Qi (Lei Qi, born August 17, 1983) is a Chinese assistant professor in the Department of Bioengineering, and Department of Chemical and Systems Biology at Stanford University. He is a core faculty fellow in the new multidiscipline Institute Stanford ChEM-H. He is most well known for his central role in the development of CRISPRi/a technologies.

Early life and education
Stanley obtained B.S. in Physics and Math from Tsinghua University, China, Master in Physics from UC Berkeley, and PhD in Bioengineering from UC Berkeley. During his PhD work at Berkeley, he studied synthetic biology with Adam Arkin, and was the first to explore CRISPR engineering for targeted gene editing and gene regulation with Jennifer Doudna. After PhD, he performed independent research work as a Faculty Fellow at UCSF. He joined Stanford faculty in 2014.

Research
Stanley is a pioneer in the CRISPR technology development. He was the inventor of the dCas9 molecule and of the CRISPR interference (CRISPRi) technology. He was a co-inventor of the UC patent on the CRISPR gene editing technology. His work led to a series of greatly expanded CRISPR technologies, including using CRISPR for gene transcription regulation, epigenetic modification, 3D genome structure organization, genome imaging, and pooled genetic screening.

Award
Stanley has won awards including NIH Director’s Early Independence Award, ,Pew Biomedical Scholar, and Alfred. P. Sloan Fellowship.